Aurora Cannabis Inc. (ACB) Key Stats Comparison | Seeking Alpha PREMIUM | Peers on Nov. 14, 2019 after Q3 earnings

1. Aurora Cannabis Inc. (ACB) Key Stats Comparison | Seeking AlphaSeeking Alpha PREMIUMSeeking AlphaSeeking Alpha
Profile ACB CGC APHA CRON TLRY HEXO
Company Name Aurora Cannabis
Inc.
Canopy Growth
Corporation
Aphria Inc. Cronos Group Inc. Tilray, Inc. HEXO Corp.
Sector Health Care Health Care Health Care Health Care Health Care Health Care
Industry Pharmaceuticals Pharmaceuticals Pharmaceuticals Pharmaceuticals Pharmaceuticals Pharmaceuticals
Market Cap 3.64B 6.41B 1.13B 2.49B 2.10B 509.76M
Enterprise Value 3.89B 5.89B 1.16B 994.46M 2.41B 420.41M
Employees 2,779 3,211 620 291 673 220
SA Authors Covering 12 10 6 5 6 4
Sell Side Analysts Covering 19 24 12 15 19 17
Ratings ACB CGC APHA CRON TLRY HEXO
Quant Rating Very Bearish Very Bearish Neutral Neutral Very Bearish Very Bearish
SA Authors Rating Neutral Neutral Neutral Neutral Bearish Neutral
Sell Side Rating Bullish Bullish Bullish Bullish Neutral Neutral
Quant Factor Grades ACB CGC APHA CRON TLRY HEXO
Value C+ C B B D+ B-
Growth A- A- A A B- A-
Profitability C- B- C A+ C+ B
Momentum D- D- D D D- D-
EPS Revisions F F A+ C F F
Valuation ACB CGC APHA CRON TLRY HEXO

2. Valuation ACB CGC APHA CRON TLRY HEXO
P/E Non-GAAP (FWD) - - 35.68 - - -
P/E Non-GAAP (TTM) - - - - - -
P/E GAAP (FWD) - - 58.66 7.82 - -
P/E GAAP (TTM) - - - 7.18 - -
PEG Non-GAAP (FWD) - - - - - -
PEG GAAP (TTM) - - - - - -
Price/Sales (TTM) 18.99 25.22 5.82 73.59 13.23 11.72
EV/Sales (TTM) 20.55 26.51 6.04 37.63 17.80 11.67
EV/EBITDA (TTM) - - - - - -
Price to Book (TTM) 1.08 1.46 0.86 1.52 5.05 0.87
Price/Cash Flow (TTM) - - - - - -
Growth ACB CGC APHA CRON TLRY HEXO
Revenue Growth (YoY) 349.20% 230.61% 477.48% 198.98% 314.45% 863.54%
Revenue Growth (FWD) 148.32% 140.26% 177.52% 245.85% 149.15% 262.71%
Revenue 3 Year (CAGR) 456.45% 152.96% 177.93% 147.93% - 193.95%
Revenue 5 Year (CAGR) - - - NM - -
EBITDA Growth (YoY) 209.43% 589.50% 198.90% 1,527.71% 186.13% 381.14%
EBITDA Growth (FWD) - - 168.24% - - -
EBITDA 3 Year (CAGR) NM NM NM NM - NM
EBIT 3 Year (CAGR) NM NM NM NM - NM
Net Income 3 Year (CAGR) NM NM NM NM - NM
EPS Growth Diluted (YoY) -293.33% 718.69% -144.26% -4,118.57% 274.82% 120.30%

3. Growth ACB CGC APHA CRON TLRY HEXO
EPS Growth Diluted (FWD) - - 11.50% - - -
EPS Diluted 3 Year (CAGR) NM NM NM NM - NM
Tang Book Value 3 Year (CAGR) 347.57% 240.53% 117.06% 365.19% - 370.22%
Total Assets 3 Year (CAGR) 568.79% 284.38% 209.01% 311.63% - 352.48%
Levered FCF 3 Year (CAGR) NM NM NM NM - NM
Profitability ACB CGC APHA CRON TLRY HEXO
Gross Profit Margin 64.46% 52.60% 4.62% 2.27% 27.03% 56.64%
EBIT Margin -119.80% -218.20% -19.50% -247.37% -82.13% -177.86%
EBITDA Margin -84.67% -197.06% -8.78% -239.43% -74.44% -171.48%
Net Income Margin -117.30% -649.08% -8.34% 4,158.35% -97.39% -171.57%
Levered FCF Margin -234.24% -347.00% -107.57% 1,180.63% -62.09% -554.12%
Return on Equity -10.03% -52.27% -1.32% 122.77% -43.73% -14.83%
Return on Assets -5.02% -7.38% -1.53% -3.61% -11.01% -8.69%
Return on Total Capital -5.47% -7.99% -1.66% -4.54% -13.14% -9.33%
Asset Turnover Ratio 0.07% 0.05% 0.13% 0.02% 0.21% 0.08%
Cash From Operations -146.79M -466.65M -54.19M -59.55M -153.57M -94.48M
Revenue Per Employee 68,122.50 52,747.80 282,907.97 39,533.18 64,086.00 17,242.39
Net Income Per Employee -79,909.65 -374,480.38 -25,725.71 3.78M -196,197.62 -75,177.69
Momentum ACB CGC APHA CRON TLRY HEXO
3 Month Price Performance -46.70% -45.91% -35.55% -47.84% -54.52% -59.72%
6 Month Price Performance -55.74% -57.72% -34.02% -49.05% -54.96% -69.76%

4. Momentum ACB CGC APHA CRON TLRY HEXO
9 Month Price Performance -51.03% -59.83% -51.73% -64.50% -72.92% -63.69%
YTD Price Performance -28.43% -31.15% -21.62% -30.13% -70.33% -41.98%
1Y Price Performance -47.01% -51.92% -56.70% -12.64% -81.24% -56.76%
3 Year Price Performance 128.50% 167.34% 30.03% 757.24% - -
5 Year Price Performance - 761.27% - - - -
EPS Revisions ACB CGC APHA CRON TLRY HEXO
EPS: FQ1 Up Revisions 0 3 1 1 1 0
EPS: FQ1 Down Revisions 4 1 0 4 7 2
Revenue: FQ1 Up Revisions 0 0 1 0 1 0
Revenue: FQ1 Down Revisions 7 11 1 2 5 6
EPS Beats (last 2 years) 5 0 6 6 0 1
Revenue Beats (last 2 years) 3 4 2 2 5 4
Dividends ACB CGC APHA CRON TLRY HEXO
Dividend Yield (FWD) - - - - - -
Dividend Yield (TTM) - - - - - -
4 Year Average Yield 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Dividend Rate (FWD) - - - - - -
Dividend Rate (TTM) - - - - - -
Payout Ratio - - - - - -
Dividend Growth 3 Yr (CAGR) - - - - - -
Dividend Growth 5 Yr (CAGR) - - - - - -

5. Dividends ACB CGC APHA CRON TLRY HEXO
Years of Dividend Growth 0 Years 0 Years 0 Years 0 Years 0 Years 0 Years
Total Return ACB CGC APHA CRON TLRY HEXO
1 Month Return -3.53% -4.79% -5.31% -7.46% -0.14% -21.34%
YTD Return -28.43% -31.15% -21.62% -30.13% -70.33% -41.98%
1 Year Return -47.01% -51.92% -56.70% -12.64% -81.24% -56.76%
3 Year Return 128.50% 167.34% 30.03% 757.24% - -
5 Year Return - 761.27% - - - -
10 Year Return - - - - - -
Income Statement (TTM) ACB CGC APHA CRON TLRY HEXO
Revenue 189.31M 222.12M 191.25M 26.43M 135.57M 36.02M
Revenue Per Share 0 1 1 0 2 0
EPS Diluted -293 719 -144 -4,119 275 120
Net Income -222.07M -1.44B -15.95M 1.10B -132.04M -61.80M
Gross Profit 122.03M 116.83M 8.83M 600,067.93 36.65M 20.40M
EBITDA -160.30M -437.72M -16.79M -63.27M -100.92M -61.77M
Operating Income -226.80M -484.66M -37.29M -65.37M -111.34M -64.06M
Net Income Avail. to Comm. -222.07M -1.44B -15.95M 1.10B -132.04M -61.80M
Balance Sheet (TTM) ACB CGC APHA CRON TLRY HEXO
Total Cash 241.26M 2.43B 348.77M 1.50B 122.37M 115.81M
Total Cash Per Share 0 7 1 4 1 0

6. Balance Sheet (TTM) ACB CGC APHA CRON TLRY HEXO
Total Debt 492.36M 1.68B 356.05M 6.16M 437.28M 25.29M
Total Debt to Equity 15 37 27 0 105 4
Short Term Debt - - - - - -
Long Term Debt 301.72M 1.57B 346.55M - 427.98M 22.92M
Current Ratio 2 10 6 3 3 6
Quick Ratio 1 9 4 3 1 4
Covered Ratio NM NM NM - NM NM
Book Value Per Share 0 7 2 4 -1 2
Debt/Free Cash Flow -1 -2 -2 - - -0
Long Term Debt/Total Capital 8 26 21 0 51 4
Cash Flow Statement (TTM) ACB CGC APHA CRON TLRY HEXO
Net Operating Cash Flow -146.79M -466.65M -54.19M -59.55M -153.57M -94.48M
Levered Free Cash Flow -443.44M -770.76M -205.73M 312.00M - -199.59M
Cash from Operations -146.79M -466.65M -54.19M -59.55M -153.57M -94.48M
Capital Expenditures -316.34M -536.49M -140.88M -69.79M - -104.58M